https://www.news-medical.net/news/20240722/Combination-of-sEphB4-HSA-and-pembrolizumab-shows-promise-in-HPV-negative-EphrinB2-positive-HNSCC.aspx
Combination of sEphB4-HSA and pembrolizumab shows promise in HPV-negative EphrinB2 positive HNSCC
Jul 23, 2024 - A new research paper was published in Oncotarget's Volume 15 on July 10, 2024, entitled, "Improved efficacy of pembrolizumab combined with soluble...